FDA Perturbed By Provention's Teplizumab Type 1 Diabetes Drug

Concerns Over Pharmacokinetics Data

 
• By Kevin Grogan
  
delays
Teplizumab approval pathway not so clear now • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Alimentary/Metabolic

More from Therapeutic Category